Skip to main content
main-content
Top

10-10-2016 | Pembrolizumab | Article

Carboplatin and pemetrexed with or without pembrolizumab for advanced, non-squamous non-small-cell lung cancer: a randomised, phase 2 cohort of the open-label KEYNOTE-021 study

Langer CJ et al. Lancet Oncol 2016; 17(11): 1497–1508. doi: 10.1016/S1470-2045(16)30498-3

Please log in to get access to this content

Related topics